enginzyme
Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products …
Profile
- Industry
- Cosmetics, Bioprocess equipment, Industrial chemistry
- Topics
- Enzymes & biocatalysis, Synthetic biology platforms & biomanufacturing
- Role
- Producer — “…ce traditional fossil-based manufacturing methods [1][4][3]. The company is privately held and recently closed…”
- Why it is bioeconomy
- EnginZyme is a biotechnology company that develops a cell-free, enzyme-based platform for sustainable chemical manufacturing and biocatalysis.
- Found via
- Novonesis; AB Enzymes; [Rubric] Finland · lipase-oils; [Rubric] Norway · lipase-oils
Bio-solutions it supplies 0
Not yet cited as a supplier in a graded solution.
What they offer
This company does not publish its products or services — we find out through an introduction.
Status
- 2026-09 Latest status: The company closed a new equity round raising SEK 75 million in September 2026 to support its shift from R&D to a commercially driven strategy. ↗ ↗ ↗
Recent news 5
Curated from verified corporate disclosures and market announcements. Review original publications for complete commercial details.
- 2026-10-02 Enginzyme Raises SEK 75 Million To Advance Commercial Biomanufacturing Strategy pulse2.comEnginzyme has raised SEK 75 million to shift from R&D toward commercial biomanufacturing, expanding adoption of its enzyme-based, cell-free manufacturing technology for personal care, food, and pharma, with new investors joining the board to support scalable, sustainable …
- 2026-09-23 Enginzyme Raises SEK 75 Million to Advance Its Commercial Biomanufacturing Strategy - BioSpace biospace.comEnginzyme has closed a SEK 75 million equity round, signaling a strategic shift from R&D toward commercial biomanufacturing in personal care, food, and pharmaceutical applications. The funding brings in new shareholders and board members to support its enzyme immobilization …
- 2026-09-23 Enginzyme AB Closes New Equity Round Raising SEK 75 Million — TradingView News tradingview.comEnginzyme AB has closed a new equity round, raising SEK 75 million, signaling investor confidence and potential growth funding for the company.
- 2026-09-23 Enginzyme Raises SEK 75 Million to Advance Its Commercial Biomanufacturing Strategy | Business Wire via.tt.seEnginzyme has raised SEK 75 million in a new equity round, signaling a strategic shift from R&D toward a commercially driven biomanufacturing agenda. The funding, including new shareholders and board members, supports its goal of delivering cost-efficient, sustainable …
- 2026-09-23 EnginZyme raises US$9.07M to shift from R&D to commercial biomanufacturing | Dealroom News dealroom.coEnginZyme has closed a US$9.07M Series C to pivot from R&D toward commercial biomanufacturing, strengthening its leadership with new investors including Lotus One Investment and Valquest Partners Europe. The funding supports scaling enzyme-based, non-chemical production across …
Network: owners, partners, peers
Ownership & investors 5
| investor | Almi Invest GreenTech |
| investor | Bunge Ventures |
| investor | Sofinnova Partners |
| investor | Industrifonden |
| investor | SEB GreenTech VC |
Similar companies
C3 Biotech · GFBiochemicals · DAB.bio · Green Biologics Ltd. · NorFalk · Biochemtex · Cascat GmbH · Arsenale Bioyards
Company facts
Registry identifiers
- Registration number: 556965-8494
Funding
- Latest round: Non equity assistance · 2024-09-05
- Total raised: US$ 34.8 M
Commercial milestones and operating metrics compiled from corporate filings, press disclosures, and registry data. Registration numbers should be cross-referenced with official state registers.
Identity & contacts
Contacts, people and legal identity are available to members.
Sign in as a member